chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st vaccine 2/2/21 - 2 months later couldn't lift left rm or reach in back pocket.  2nd vaccine 2/23/21 - 2 months later couldn't left right arm or reach in back pocket.  Identical pain & symptons.  Like flapping your arms like a bird and can't.  Easiest way to describe it.  Pain is dissipating in right, but left arm still very painful.
Menstrual cycle has been irregular each month since getting the vaccine. I am experiencing vaginal bleeding again today (08/21/2021) despite my cycle (which lasted for exactly 7 days- the usual amount of days I have it) ending exactly week ago. I have had random bleeding all throughout each month since getting the vaccine, as well as increased painful symptoms such as  cramping which I have rarely ever had before.
Patient experienced itching 2 days after vaccination over various parts of body. Itching reported on both arms, fingers, nipples, buttocks, legs, and trunk.
administered Boostirx and Menactra was fine. Then administered Garadasil and client with in 1 minute became white and slummped in chair, eyes rolled back and began to have a seizure lasting about 30 sec. Noted arms tightening and legs moving during seizure. Client awoke but very pale laid on cot and rested for 15 minutes MD called and reported blood pressure of 102/60. Client after 15 min sat up for 10 minutes then walked outside. MD advised if episode happens again to take to ER. No history of seizures or medical problems. Client was showing no signs of nervousness when she came into room even joking with nurse.
Client presented to clinic, did not inform staff that he had received first dose on 1/30/2020 at another site. Second dose administered unknowingly outside of 28 day time frame.
Moderna COVID-19 Vaccine EUA Underage patient was inappropriately vaccinated with Moderna product; no adverse effects
77-year-old male with past medical history of atrial fibrillation, stomach cancer, hypertension, history of small-bowel obstruction presents to the emergency department with shortness of breath and sore throat.  Patient's wife at is admitted to the hospital currently also diagnosed with COVID-19 which is likely where he caught the virus.  Tolerating nasal cannula currently.  At rest can sometimes maintain oxygen saturation off nasal cannula.  Does not appear to be septic.  No nausea vomiting or diarrhea.   Was complaining of some pain in his legs which appeared to be neuropathic in origin. 8/7/2021 tested positive 8/10/2021 patient discharged.
Upper arm swelling towards arm fold and extending towards forearm. The arm at 24 hours had a light red rash. It was also hot to the touch. Unable to comfortably bend elbow or lay on left side. At 48 hours, the arm swelled more with the redness deepening. Still difficulty bending elbow, area is hot to the touch.
REDNESS, SORENESS, ITCHING @ SITE, HIVES ON BACK, LEG & BUTTOCK ON 6-3-08 AROUND 9:30 PM
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 19Sep2022 at 20:45 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: HYDROXYCHLOROQUINE, start date: 30Sep2022, stop date: 09Oct2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: indication=Treatment of COVID-19; Positive, notes: Rebound COVID 19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that anti-viral details for product=COVID 19 Treatment, start date was on 30Sep2022, stop date was on 05Oct2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Vasovagal. Patient unexpectedly went unresponsive. responded to name and woke up.
Had DTaP right arm deltoid on 12/20/2000, arm red and swollen to elbow, told nurse 2/5/03 when next DTaP was due.
dizziness (intermittent); This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 07Jan2021 at 16:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took ciprofloxacin (CIPRO) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 08Jan2021 at 07:00, the patient experienced dizziness (reported as intermittent for 5 days). Patient was given an unspecified treatment for the event. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the event was recovering.  Information on the lot/batch number has been requested.
Got shingles, and lower back pain. Couldn't stand for two days . Got headache, low grade fever, and nausea., fatigue. Swollen eye, sores covering left side of face, and itching, and pain. Went to the dermetologist and eye doctor. Now on two medications (Valtrex 3000 ml, Gavapiton, 300ml) Medication daily, bed rest 20 hours for 7 days.  Doctor's diagnosis was shingles.
could not move my arm; it was like glued to the side of my arm/such pain; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age  (reported as 78: unknown unit) received her first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date not reported), via an unspecified route of administration on an unspecified date at SINGLE DOSE for Covid-9 immunisation. Medical history included hip replacement last year (2020) and informed that it was that much pain. The patient's concomitant medications were not reported. The patient reported that she could not move her arm. It was like glued to the side of her arm and informed that she never had such pain on an unspecified date. At the slightest touch she would scream. Her neighbor put her arm in a sling. She took Tylenol also as treatment. She was scheduled for her 2nd shot and was asking if this will happen again. The outcome of event was recovering (today was a little better).   Information on the Lot/Batch number has been requested
three 16 year old patients received their first dose of the Moderna vaccine; A spontaneous report  was received from a pharmacist concerning three 16 year old patients who were administered a COVID vaccine at an inappropriate age.    The patient's medical histories were not provided.  Concomitant medication details were not provided  On an unreported date, the patients received their first of two planned doses of mRNA-1273 (Batch numbers: 039K20A, 011L20A, 013L20A) some time between 11/Jan/2021 and 21/Jan/2021 intramuscularly for prophylaxis of COVID-19 infection.   On an unreported date,  three 16 year old patients were administered a COVID vaccine at an inappropriate age. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The event was considered resolved on an unreported date.; Reporter's Comments: This report refers to a case series of three (3) individual 16-year-old patients who each experienced the nonserious unexpected event of 'PT Product administered to patient of inappropriate age' for the first dose of mRNA-1273 (mRNA-1273 lots # 039K20A, 011L20A, 013L20A), with no associated adverse events in any patient. Very limited information regarding this event has been provided at this time.  Further information has been requested.
Felt pain in Right shoulder after flu inection into deltoid. Thought the pain would resolve after 2-3 days but continued to feel sore. Hurts with any over head motions or with internal rotation. Denies swelling or erythema
This case meets criteria for vaccine breakthrough review. SxS include "cold-like" symptoms.  Hospitalized after seizure.
I cannot make this form work properly. The adverse reaction was in 1973. My mother woke me up at about 1 PM wondering why I had slept so late. My colon had emptied itself into the bed and if she had not awakened me I don't know if I would ever have awakened. I was in bed for a week after that!
T wave inversion in lateral leads and ST segment elevation in V2-V6; This is a literature report  A 14 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (medically significant), outcome "unknown", described as "T wave inversion in lateral leads and ST segment elevation in V2-V6". The patient underwent the following laboratory tests and procedures: blood test: negative; brain natriuretic peptide: 37 pg/mL; c-reactive protein: 5.03 mg/dl; 5.03 mg/dl, notes: on admission; 4.04 mg/dl, notes: on discharge; cytomegalovirus test: negative; electrocardiogram: t wave inversion, notes: in lateral leads and ST segment elevation in V2-V6; epstein-barr virus test: negative; influenza a virus test: negative; investigation: negative; parvovirus b19 test: negative; polymerase chain reaction: negative; respiratory syncytial virus test: negative; troponin i: 7.61 ng/dL; 5.52 ng/dL, notes: on admission; 3.68 ng/dL, notes: on discharge.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the event and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.  The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200257419 same article/drug/event and different patient;US-PFIZER INC-202200283444 same article/drug and different patient /event
Shortly after receiving the Flu shot, pt said he felt "lightheaded." His mother instructed him to lie down on the floor. After a few minutes of this, he felt better and got up w/o any further problems/complaints.
Cold-like symptoms.  Runny nose.  No aches, no fatigue, no fever.
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 9:31 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Mar-2021 at 9:31 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 69.95.   No concomitant product use was reported.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Vial was stored in cooler 1, on 02-Mar-2021, Excursion duration at 9 am: 27, at 10 am 29, at 11 am 32, at 12 am 33, at 1 pm 36, at 2 pm 35, at 3 pm 36, at 4 pm 37 and at 5 pm 37.  On 02-Mar-2021, total doses given for the day was 177, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 02-Mar-2021. 16 vial was moved to clinic. Vaccine BUD date was 26-Mar-2021.  On 30-Mar-2021, total doses given for the day was 173, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 30-Mar-2021. 3 vial was moved to clinic. Vaccine BUD date was 22-Apr-2021.  Vials only punctured right before administration.  No treatment information was provided.
Information has been received from a physician concerning an 11 year old female who in August 2007, was vaccinated with the first dose of GARDASIL. "The same day of the vaccination", after receiving the vaccination, the patient passed out in the office. On unspecified date, the patient recovered. Follow up information was received from someone at the physician's office. The person reported "this was over a year ago." She also reported "the patient passed out with the first dose". The administering nurse no longer works at the office and no one can recall the patient. I t was reported that the patient recovered within minutes of injection. No further information was available.
first dose on February 28, 2020; This case was reported by a consumer via media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 28th February 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The patient asked, if it was okay to get 2nd dose if the 1st dose was on 28th February 2020.
Information has been received from a medical assistant concerning an over 60 year old male with "pulmonary issues" who in June 2006, was vaccinated with a dose of Pneumovax 23 (lot #651320/1008P). Subsequently, in June 2006, the patient experienced cellulitis. Unspecified medical attention was sought. No lab studies were performed. At the time of report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Pt was seated in observation area about 10 min post Covid vaccination and stated he was feeling flushed and dizzy. Face and arms with visible redness, assisted to cot and VS taken 102/70-76-14 pulse ox 97%.  Denies SOB and no difficulty of breathing noted.  Abdominal area redness observed and some blanching of the lower arms noted.   Denies allergies other then Codeine-Rxn anxiety.  Benadryl 50mg PO give at 1:55pm. Pt here with another man who states he is a friend and another man who drove them to appt came in to clinic.  Pt observed for 20 min and instructions given for symptoms constituting a 911 call.  Friend expresses that he wants to leave.  Instructions given to friend who states he will stay with Pt for the next 2 hrs.  Pt states he is feeling well enough to ambulate, ambulates with steady gait with friend to car and conveys understanding of when to call 911 if needed.
I started to have a headache, scratchy throat, congestion, body aches. I was miserable for about 10 days. I rested and drank lots of fluids. I took ibuprofen and Tylenol as needed. I completely recovered after the 10 day period but begun to have additional symptoms 2 weeks later. It felt like I had a UTI. It lasted for several weeks so I went in to GYN specialist who referred me to a website for interstitial cystitis. She stated there was evidence that this condition happens sometimes after COVID. I am still experiencing symptoms from it. I had to make dramatic changes to my diet.
Patient had vasovagal syncopal event shortly after administration. Felt flushed immediately after shot and was seated for about 5 minutes. She tried to stand up and slowly fell forward to the ground. Pharmacist and patient's husband responded immediately. Patient woke up on floor almost right away. She had some water and was monitored for another 20 minutes before she left by her own choice.
4 hrs p/vax pt cranky, shrill crying noise, lost consciousness, turned blue from lack of oxygen 30 mins later if occured again; during hosp stay the sleep apnea machine showed a lulls in resp; entire hosp stay of 2 days & 2 noc;
Patient stated that shortly after getting the Pfizer vaccine she started having unexpected menstrual bleeding which continued for 7 days.  She also had abdominal cramping that was 100X worse than her previous menstrual cramps.  The cramps went on for 3 days.  She discharged clots while bleeding and she also states that she had really bad "medical smelling" gas for about 2 weeks.  She did have diarrhea and lasted for about 2 weeks as well.
loss of smell; most foods have no flavor except for the taste on tongue/pleasure of eating a good meal is lost; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:. The reporter is the patient.  An elderly male patient received bnt162b2 (COMIRNATY), on 31Mar2021 as dose 2, single (Lot number: ER2613) at the age of 83 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NOVOLIN 70/30 (ongoing); PRESERVISION AREDS 2 (ongoing). Vaccination history included: comirnaty (DOSE 1; Lot number: EN6198 in the left upper arm), administration date: 20Feb2021, when the patient was 83-year-old, for COVID-19 immunisation. The following information was reported: ANOSMIA (non-serious) with onset 2021, outcome "unknown", described as "loss of smell"; DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "most foods have no flavor except for the taste on tongue/pleasure of eating a good meal is lost".  Additional information: The patient received Pfizer's COVID-19 vaccine for each of the injections made available to the American public. The first injection, and each of the following, thereafter affected sense of smell. The patient states that if this continues, he will never smell again. This is frustrating for him as most foods have no flavor except for the taste on his tongue. The pleasure of eating a good meal is lost. Every vaccine he has received, he has a loss of smell and gets a little better and gets next dose or booster vaccine and loses sense of smell again. Just got latest Pfizer Covid vaccine and it happened again.  He cannot identify any smells and can tell difference between some foods but not what they are; it makes a big difference on what he enjoys. The first time noticed the loss of smell was after the first two initial vaccinations he got a month apart. He remembers it was after the 2nd dose is when he realized what was going on. It has stayed about the same, it got a little better and when he got the next booster shot it went back. That happens each time he gets booster shot. He doesn't know how to explain improvement, he can tell a little difference between fruit or maple syrup but not the flavors for example. If he has a hot cup coffee in front of him, he can't smell it. But it tastes different, something there but doesn't know what it is.
Hives on my neck, came out around 4 hour post shot mark. Itchy and red.
1 1/2 hrs /p vax began T 105.2, fever reduced /w meds, Seen by MD had T 103 & conjuctivitis, seen again by MD T 102 & Dx bilateral otitis media
on 7/15/2020 Pea size hard, warm, skin area to Right arm.  On 7/16/2020, Softball size hot red sore area to back of right arm.   C/O rash, itching to area behind knees to inner thighs under areas of both arms.  Patient saw local PMP and states she was told she was having an adverse allergic reaction to a component of Varicella.  Gave her a prescription with an histamine
Breakthrough symptomatic COVID-19 infection- onset 10/5/21, positive PCR 10/7/21 Respiratory failure, cough, chills, nausea, vomiting, diarrhea, and myalgias
Pt was inadvertnatly give Pfizer 2nd dose after Moderna initial dose.
following vax pt exp difficulty breathing/SOB soon followed by sz like activity & increasing temp from 98 to 104.8 in 20-30mins; tremor
Pink eye - onset 12/06/2012 still present today (12/12/2012) Right eye Fever - (around 100 degrees) - onset 12/06/2012 ending 12/09/2012 Tylenol administered until fever broke. Rash - onset 12/09/2012 still present today (12/12/2012) Red bumps, mainly on the right side of face and some on left side of face. "Blotchy" on face as well.
Initial and follow up information has been received from a health professional concerning an 39 yr old female with allergy to codeine who on 10Nov04 was vaccinated IM left deltoid with a dose of pneumococcal 23v polysaccharide vaccine (Lot 649111/0287P). It was reported that there was no concomitant medication and no lab diagnostic tests were performed. Subsequently the pt developed redness, pain and swelling. In follow up, the health professional reported that on 11Nov04 the pt developed redness, pain and swelling at the injection site. The pt was treated with ice application to alleviate pain. It was also reported that the pt fully recovered. No product quality complaint was involved. It was also reported that there were three other pt who experienced adverse events after administered of pneumococcal 23v polysaccharide vaccine (Lot 649111/0287P) (WAES0411USA02642, 0411USA03941, 0411USA03943).  No additional information is expected.
Pt noticed that PPD site was large and then noticed that arm where varicella was given was swollen as well